- Home
- AUTL vs GMRE Comparison
AUTL vs GMRE Comparison
Compare AUTL & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- GMRE
- Stock Information
- Founded
- AUTL 2014
- GMRE 2011
- Country
- AUTL United Kingdom
- GMRE United States
- Employees
- AUTL N/A
- GMRE N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- GMRE Real Estate Investment Trusts
- Sector
- AUTL Health Care
- GMRE Real Estate
- Exchange
- AUTL Nasdaq
- GMRE Nasdaq
- Market Cap
- AUTL 625.4M
- GMRE 508.9M
- IPO Year
- AUTL 2018
- GMRE N/A
- Fundamental
- Price
- AUTL $1.38
- GMRE $7.73
- Analyst Decision
- AUTL Strong Buy
- GMRE Buy
- Analyst Count
- AUTL 5
- GMRE 3
- Target Price
- AUTL $9.12
- GMRE $10.38
- AVG Volume (30 Days)
- AUTL 4.4M
- GMRE 691.1K
- Earning Date
- AUTL 11-11-2025
- GMRE 11-05-2025
- Dividend Yield
- AUTL N/A
- GMRE 7.85%
- EPS Growth
- AUTL N/A
- GMRE N/A
- EPS
- AUTL N/A
- GMRE 0.07
- Revenue
- AUTL $29,934,000.00
- GMRE $141,896,000.00
- Revenue This Year
- AUTL $634.25
- GMRE $7.69
- Revenue Next Year
- AUTL $93.16
- GMRE $4.04
- P/E Ratio
- AUTL N/A
- GMRE $113.85
- Revenue Growth
- AUTL 185.17
- GMRE 2.95
- 52 Week Low
- AUTL $1.11
- GMRE $6.06
- 52 Week High
- AUTL $5.00
- GMRE $10.46
- Technical
- Relative Strength Index (RSI)
- AUTL 28.28
- GMRE 66.58
- Support Level
- AUTL $1.34
- GMRE $7.26
- Resistance Level
- AUTL $1.46
- GMRE $7.73
- Average True Range (ATR)
- AUTL 0.09
- GMRE 0.15
- MACD
- AUTL 0.01
- GMRE 0.02
- Stochastic Oscillator
- AUTL 9.09
- GMRE 95.70
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.